A First-in-Patient Study to Evaluate the Safety and Tolerability of HB-2121 as a Diagnostic for Celiac Disease

Name: A First-in-Patient Study to Evaluate the Safety and Tolerability of HB-2121 as a Diagnostic for Celiac Disease
Published: 2026
License: Public Domain

Nielsen Fernandez-Becker · 2026

ClinicalTrials.gov · Datasets · License: Public Domain · 2026

Open Source ↗

celiac disease, hb-2121, gluten intolerance, esophagogastroduodenoscopy, interventional, phase1

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

A First-in-Patient Study to Evaluate the Safety and Tolerability of HB-2121 as a Diagnostic for Celiac Disease

Related documents